Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
61-75 of 4215 results
Zymeworks, GSK enter second collaboration to develop bi-specific antibodies
Zymeworks has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific antibodies enabled using Zymeworks’ Azymetric drug discovery platform.
Drug Research > Drug Discovery & Development > News
NewLink Genetics wins $21.6m contract option from BARDA for Ebola vaccine development
NewLink Genetics announced that the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human Services (HHS) has exercised its $21.6m option to support continued development of the investigational rVSV-ZEBOV-GP (Ebola) vaccine candidate.
Drug Research > Drug Discovery & Development > News
hVIVO, SEEK to work together to develop vaccines against Flu and Zika infections
By PBR Staff Writer
hVIVO has unveiled a joint venture (JV) investment with the SEEK Group for the development of vaccines against influenza and mosquito-borne diseases like the Zika virus and other flaviviruses.
Drug Research > Drug Discovery & Development > News
AstraZeneca launches genomics initiative to transform drug discovery and development
By PBR Staff Writer
AstraZeneca has launched a new initiative to screen around two million genomes sequences for information that will guide in advancing drug discovery and development across its research and development platforms.
Drug Research > Drug Discovery & Development > News
Aptuit acquires Exquiron Biotech
Aptuit has acquired Exquiron Biotech to meet customer demand for fully integrated outsourced discovery services.
Drug Research > Drug Discovery & Development > News
SBP, GSK create new center for translational neuroscience
Sanford Burnham Prebys Medical Discovery Institute (SBP) and GlaxoSmithKline (GSK) have created the SBP-GSK Center for Translational Neuroscience.
Drug Research > Drug Discovery & Development > News
Yabao Pharmaceutical, Salus Pharma partner to develop generic drugs
Yabao Pharmaceutical and Salus Pharma have announced a strategic partnership to co-develop, manufacture and commercialize high technological barrier generic drugs worldwide.
Drug Research > Drug Discovery & Development > News
Second Genome secures $42.6m funding to expand microbiome discovery platform
Second Genome, a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, has closed an oversubscribed Series B investment round with $42.6m in financing.
Drug Research > Drug Discovery & Development > News
DalCor completes $150m financing to continue development of dalcetrapib in ACS
By PBR Staff Writer
DalCor Pharmaceuticals has wrapped up a private financing round valued at $150m to continue the development of dalcetrapib in genetically distinct patients with acute coronary syndrome (ACS).
Drug Research > Drug Discovery & Development > News
NanoAntibiotics acquires biotechnology firm LAT Pharma
NanoAntibiotics has acquired LAT Pharma LLC, of Chicago, IL, an early-stage biotechnology company developing novel medicines to treat life-threatening complications of liver cirrhosis.
Drug Research > Drug Discovery & Development > News
Sunny Pharmtech and Vitruvias partner to co-develop several high value generic drugs
Sunny Pharmtech and Vitruvias Therapeutics have signed two additional agreements to co-develop and market two additional high-value generic drugs.
Drug Research > Drug Discovery & Development > News
Heptares, Kymab partner to develop novel antibody therapeutics
By PBR Staff Writer
Heptares Therapeutics and Kymab have partnered to discover, develop and commercialize novel antibody therapeutics.
Drug Research > Drug Discovery & Development > News
WuXi AppTec acquires Crelux to improve structure-based drug discovery capabilities
WuXi AppTec has acquired Crelux, a structure based drug discovery provider based in Munich, Germany
Drug Research > Drug Discovery & Development > News
Transplant Genomics, Quark Pharmaceuticals form discovery and development collaboration
Transplant Genomics ("TGI") and Quark Pharmaceuticals announced their joint intent to pursue a discovery and development collaboration involving the use of TGI's TruGraf blood test in a Phase 3 clinical trial involving patients being treated for delayed graft function (DGF) with Quark's proprietary drug candidate QPI-1002.
Drug Research > Drug Discovery & Development > News
Cydan Development launches second orphan drug company
By PBR Staff Writer
Cydan Development has launched its second orphan drug firm, Imara, and raised $31m in a Series A round from a group of investors including Pfizer Venture Investments and New Enterprise Associates.
Drug Research > Drug Discovery & Development > News
61-75 of 4215 results